David Leighton Email & Phone Number

California, United States

South San Francisco, California, United States

South San Francisco, California, United States

Led the design and delivery of comprehensive training programs for 135+ sales representatives. Facilitated both in-person and remote training sessions. Played a pivotal role as the Co-Lead for PD-L1 Immunotherapy and Lead for the Small Molecule TKI Portfolio and Dermatology sectors. Demonstrated deep knowledge and expertise across a range of products including Tecentriq, Alecensa, Rozytrek, Gavreto, and Erivedge. Received multiple awards for outstanding contributions in business impact, innovation, and collaboration. Served as the Culture Team Lead for 2.5 years, a role conferred by both peers and leadership. This Team improved anonymous employee ratings of psychological safety, inclusion, and a speak up culture. Created customized new-hire roadmaps, catering specifically to an individual’s varying levels of experience upon joining the field force. Fluent with several interactive learning technologies to reinforce learning and retention (see page 2).Successfully contracted and coached key opinion leaders (KOLs) to deliver specialized training, enhancing the educational impact and credibility of the sales force. Played key roles in the successful launches of new products, line extensions, and expansion of sales teams within the highly competitive fields of oncology, biomarker testing, dermatology.

South San Francisco, California, United States

Developed and implemented clinical and sales training programs for two large field sales forces, encompassing a total of 100 representatives. Led the development and mentorship of 12 field-based trainers.Focused on a diverse range of products including Herceptin, Kadcyla, Perjeta, Erivedge, and Xolair.Co-developed cross-training for Dermatology reps on Xolair for Chronic Spontaneous Urticaria (CSU).Effectively leveraged extensive experience in oncology sales and biomarker expertise to deliver high-quality, specialized training. Fostered strong relationships through collaboration with multiple internal stakeholders and external vendors. Actively partnered with Thought Leader Liaisons to manage, contract, and coach key opinion leaders (KOLs).

South San Francisco, Ca

Served as the sole trainer for 32 personalized medicine specialists within the Biomarker Testing Team.Delivered comprehensive training encompassing both technical and soft skills, thereby enhancing the capabilities of multidisciplinary cancer teams. Conducted training that emphasized guideline-based pre-analytics, testing, and reporting processes for various malignancies, which directly led to adoption of Genentech’s targeted therapies. Specialized in key biomarkers including HER2, ER, PR, PD-L1, showcasing knowledge in critical testing parameters relevant to personalized medicine. Managed a large budget, collaborated with vendors, developed speakers, and aligned with training initiatives with marketing and brand strategies.

Michigan, Ohio, And Northeast States

Selected for a Genentech pilot program to provide critical guideline-based education to multidisciplinary stakeholders, including regional reference labs, academic centers, and large hospital systems. Managed key accounts in a 12-State Territory.Served as a Field-Based Trainer, contributing to the professional development of the team. Participated on the interview panel for three significant organizational expansions between 2012 and 2014. Instrumental in implementing 18 significant changes in cancer clinics and labs over a two-year period, effectively aligning with Management by Objectives (MBOs) and enhancing operational efficacy. Invited as a Keynote Speaker for three State Cancer Registrar Associations, sharing expertise on“Guidelines for Her2 & EGFR Testing”, with an audience of 250 registrars.

South San Francisco, California, United States

As a Clinical Oncology Specialist, I spearheaded the promotion of Herceptin, a monoclonal antibody, for treating patients with HER2 Positive Breast and Gastroesophageal Adenocarcinoma (GEA). Targeted and effectively engaged both university and community-based medical practices, increasing awareness and adoption of this critical treatment. Demonstrated exceptional sales performance, consistency exceeding 100% of the Planned Target Performance (PTP) from 2008 to 2011.Initiated concept and contributed significantly to the production of “From Surgery to the Pathology Report”, an innovative training video. This resource continues to be used for new-hire onboarding.

Successfully led the launch of a self injectable, subcutaneous biologic (Enbrel), a treatment for Psoriatic Arthritis and Psoriasis. This involved coordinating launch strategies, education healthcare professionals, and positioning the product in a competitive market.Orchestrated and delivered a series of regional and local speaking programs aimed at increasing product awareness and education among healthcare professionals. Served as a Field Trainer for 9 sales representatives, providing them with the necessary training and support to excel in their roles. District and National Field-Based Sales Trainer.

Successfully drove business for Leukine (GM-CSF) for myelosuppression and Novantrone (Mitoxantrone) for Prostate Cancer and Multiple Sclerosis.

Specialty Representative - Sold Corlopam I.V. (fenoldopam) for Severe/Malignant Hypertension or Hypertensive Emergencies. Promoted Diastat (unique diazepam formulation) for seizures in the ER setting.

Successfully re-instated CIPRO on the formulary at University of Michigan after one year absence. Promoted to the role of Medical Science Liaison, specializing in Alzheimer’s and Hyperlipidemia agents. Played a critical role in bridging the gap between clinical development and clinical practice, providing information and insights to healthcare professionals.